Physician profile
Rupal Trivedi
NPI 1154463578
$739.93
in general payments reported to CMS, 2019-2025
8 companies · $25.13 in 2025
The $25.13 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $363 · 2023: $248 · 2024: $104 · 2025: $25.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $377.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $147.97 | 2023-2025 | Coroflow, Cardiomems |
| Boston Scientific Corporation | $141.85 | 2021-2024 | Watchman Flx |
| Impulse Dynamics (USA) INC. | $127.16 | 2021 | |
| Amgen INC. | $124.90 | 2023 | Repatha |
| Coherus Oncology, INC. | $115.23 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $36.52 | 2024 | Eliquis |
| Abiomed | $28.88 | 2024 | |
| Medtronic, INC. | $17.42 | 2024 | Cobalt Dr Mri Surescan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rupal Trivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.